Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.486 EUR
−72.80 M EUR
8.43 M EUR
119.69 M
About BENEVOLENTAI
Sector
Industry
Headquarters
London
Website
Founded
2021
ISIN
LU2355630455
FIGI
BBG011N2QGR3
BenevolentAI SA is a holding company, which engages in the research and development and sale of AI-enabled drugs. Its business platform combines artificial intelligence and machine learning in discovering medicines. It operates through the UK and Europe geographical segments. The company was founded by Ivan Griffin, Kenneth Patrick Mulvany, and Michael Brennan in November 2013 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BAI is 0.375 EUR — it has decreased by −3.85% in the past 24 hours. Watch BENEVOLENTAI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BENEVOLENTAI stocks are traded under the ticker BAI.
BAI stock has fallen by −21.71% compared to the previous week, the month change is a −49.46% fall, over the last year BENEVOLENTAI has showed a −31.82% decrease.
We've gathered analysts' opinions on BENEVOLENTAI future price: according to them, BAI price has a max estimate of 3.94 EUR and a min estimate of 0.91 EUR. Watch BAI chart and read a more detailed BENEVOLENTAI stock forecast: see what analysts think of BENEVOLENTAI and suggest that you do with its stocks.
BAI stock is 9.95% volatile and has beta coefficient of −0.11. Track BENEVOLENTAI stock price on the chart and check out the list of the most volatile stocks — is BENEVOLENTAI there?
Today BENEVOLENTAI has the market capitalization of 46.81 M, it has decreased by −39.73% over the last week.
Yes, you can track BENEVOLENTAI financials in yearly and quarterly reports right on TradingView.
BENEVOLENTAI is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
BAI earnings for the last half-year are −0.22 EUR per share, whereas the estimation was −0.19 EUR, resulting in a −14.71% surprise. The estimated earnings for the next half-year are −0.03 EUR per share. See more details about BENEVOLENTAI earnings.
BENEVOLENTAI revenue for the last half-year amounts to 3.35 M EUR, despite the estimated figure of 9.44 M EUR. In the next half-year revenue is expected to reach 33.99 M EUR.
BAI net income for the last half-year is −29.02 M EUR, while the previous report showed −30.82 M EUR of net income which accounts for 5.85% change. Track more BENEVOLENTAI financial stats to get the full picture.
No, BAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 248.00 employees. See our rating of the largest employees — is BENEVOLENTAI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BENEVOLENTAI EBITDA is −72.24 M EUR, and current EBITDA margin is −957.50%. See more stats in BENEVOLENTAI financial statements.
Like other stocks, BAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BENEVOLENTAI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BENEVOLENTAI technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BENEVOLENTAI stock shows the sell signal. See more of BENEVOLENTAI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.